Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income		$ 1,424,857	$ 1,105,869
Adjustments to reconcile net income to net cash provided by operating activities -
Amortization of deferred financing costs		24,015	24,263
Adjustment to operating lease right-of-use asset and liability		1,224	1,192
Depreciation		469	587
Non-cash compensation expense		3,266	3,266
Changes in operating assets and liabilities:
Interest receivable on loans		(73,474)	(87,896)
Other assets		(27,280)	(14,998)
Accounts payable and accrued expenses		(5,958)	(38,587)
Deferred origination fees		107,772	71,289
Net cash provided by operating activities		1,454,891	1,064,985
Cash flows from investing activities:
Issuance of short term loans		(18,295,339)	(9,659,678)
Collections received from loans		15,572,367	9,267,410
Net cash used in investing activities		(2,722,972)	(392,268)
Cash flows from financing activities:
Proceeds from line of credit, net		2,743,588	132,174
Dividend paid		(1,436,868)	(1,058,194)
Deferred financing costs incurred		(35,819)
Net cash provided by (used in) financing activities		1,270,901	(926,020)
Net increase (decrease) in cash		2,820	(253,303)
Cash and restricted cash, beginning of year	[1]	142,546	459,137
Cash and restricted cash, end of period	[1]	145,366	205,834
Supplemental Cash Flow Information:
Interest paid during the period		277,757	302,160
Operating leases paid during the period		15,881	15,849
Supplemental Information – Noncash Information:
Dividend declared and payable		$ 1,436,868

[1] At January 1, 2021, cash and restricted cash included $327,483